Search Results - "Schürfeld, Carsten"

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis by Taylan, Christina, Driemeyer, Joenna, Schmitt, Claus P., Pape, Lars, Büscher, Rainer, Galiano, Matthias, König, Jens, Schürfeld, Carsten, Spitthöver, Ralf, Versen, Axel, Koziolek, Michael, Marsen, Tobias A., Stein, Holger, Schaefer, Juergen R., Heibges, Andreas, Klingel, Reinhard, Oh, Jun, Weber, Lutz T., Klaus, Günter

“…Twenty-four patients with bi-allelic familial hypercholesterolemia commencing chronic lipoprotein apheresis (LA) at a mean age of 8.5 ± 3.1 years were analysed…”
Get full text

Case report—Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia by Katzmann, Julius, Schürfeld, Carsten, März, Winfried, Laufs, Ulrich

“…Xanthomas are visibly deforming cholesterol deposits that develop after long-term exposure to high serum low-density lipoprotein cholesterol concentrations. We…”
Get full text

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity by Klaus, Günter, Taylan, Christina, Büscher, Rainer, Schmitt, Claus Peter, Pape, Lars, Oh, Jun, Driemeyer, Joenna, Galiano, Matthias, König, Jens, Schürfeld, Carsten, Spitthöver, Ralf, Schaefer, Juergen R., Weber, Lutz T., Heibges, Andreas, Klingel, Reinhard

“…Background Familial hypercholesterolemia (FH) causes premature cardiovascular disease (CVD). Lipoprotein apheresis (LA) is recommended as first-line…”
Get full text

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis by Spitthöver, Ralf, Röseler, Tilmann, Julius, Ulrich, Heigl, Franz, Schettler, Volker J. J., Kühn, Ralf, Leebmann, Josef, Raabe, Andrea, Knittel, Markus, Schürfeld, Carsten, Moesenthin, Michael, Bernhardt, Wanja M., Röseler, Eberhard, Ketteler, Markus, Heibges, Andreas, Klingel, Reinhard

“…Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid‐lowering…”
Get full text

Xanthome verschwinden, Atherosklerose bleibt by Seiler-Mußler, Sarah, Schürfeld, Carsten, Laufs, Ulrich

Get full text